DK0502146T3 - Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE - Google Patents

Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE

Info

Publication number
DK0502146T3
DK0502146T3 DK91915865T DK91915865T DK0502146T3 DK 0502146 T3 DK0502146 T3 DK 0502146T3 DK 91915865 T DK91915865 T DK 91915865T DK 91915865 T DK91915865 T DK 91915865T DK 0502146 T3 DK0502146 T3 DK 0502146T3
Authority
DK
Denmark
Prior art keywords
marek
disease
dna segment
segment encoding
herpesvirus
Prior art date
Application number
DK91915865T
Other languages
English (en)
Inventor
Leland F Velicer
Peter Brunovskis
Paul M Coussens
Original Assignee
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27075921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0502146(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/572,711 external-priority patent/US5138033A/en
Application filed by Univ Michigan State filed Critical Univ Michigan State
Application granted granted Critical
Publication of DK0502146T3 publication Critical patent/DK0502146T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK91915865T 1990-08-24 1991-08-19 Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE DK0502146T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/572,711 US5138033A (en) 1990-08-24 1990-08-24 Marek's disease herpesvirus glycoproteins GE
US07/736,335 US6087127A (en) 1990-08-24 1991-07-25 Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE
PCT/US1991/005870 WO1992003547A1 (en) 1990-08-24 1991-08-19 MAREK'S DISEASE HERPESVIRUS DNA SEGMENT ENCODING GLYCOPROTEINS, gD, gI AND gE

Publications (1)

Publication Number Publication Date
DK0502146T3 true DK0502146T3 (da) 1998-07-27

Family

ID=27075921

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915865T DK0502146T3 (da) 1990-08-24 1991-08-19 Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE

Country Status (11)

Country Link
US (2) US6087127A (da)
EP (1) EP0502146B1 (da)
JP (1) JP2527872B2 (da)
AT (1) ATE160376T1 (da)
AU (1) AU636247B2 (da)
CA (1) CA2066160A1 (da)
DE (1) DE69128239T2 (da)
DK (1) DK0502146T3 (da)
ES (1) ES2110999T3 (da)
GR (1) GR3025821T3 (da)
WO (1) WO1992003547A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2056565T3 (es) * 1990-07-30 1994-10-01 Akzo Nobel Nv Virus recombinante de la enfermedad de marek.
AU657144B2 (en) * 1991-07-09 1995-03-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US6875856B2 (en) 1993-09-24 2005-04-05 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
CA2216139C (en) * 1995-03-23 2013-01-08 Syntro Corporation Recombinant infectious laryngotracheitis virus and uses thereof
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
CN116042709B (zh) * 2022-09-23 2025-01-14 广西大学 一种共表达马立克病病毒糖蛋白gC和gD的DNA疫苗构建方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434721B1 (en) * 1988-09-13 2000-03-15 Merial Viral nucleotide sequences
ES2056565T3 (es) * 1990-07-30 1994-10-01 Akzo Nobel Nv Virus recombinante de la enfermedad de marek.
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
CA2127700C (en) * 1992-01-13 2006-06-20 Enzo Paoletti Marek's disease virus recombinant poxvirus vaccine

Also Published As

Publication number Publication date
JP2527872B2 (ja) 1996-08-28
WO1992003547A1 (en) 1992-03-05
ATE160376T1 (de) 1997-12-15
JPH04505106A (ja) 1992-09-10
US6087127A (en) 2000-07-11
ES2110999T3 (es) 1998-03-01
US5976787A (en) 1999-11-02
AU8496591A (en) 1992-03-17
EP0502146B1 (en) 1997-11-19
CA2066160A1 (en) 1992-02-25
GR3025821T3 (en) 1998-03-31
AU636247B2 (en) 1993-04-22
DE69128239D1 (de) 1998-01-02
DE69128239T2 (de) 1998-03-12
EP0502146A4 (da) 1994-08-03
EP0502146A1 (en) 1992-09-09

Similar Documents

Publication Publication Date Title
DE69333397D1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
ES2193133T3 (es) Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
EP0841941A4 (en) Novel non-pyrogenic bacterial strains and their use
EP0744958A4 (en) LIBRARIES MADE OF POLYCLONAL ANTIBODIES
NO20000850L (no) Vaksine
ES2001752A6 (es) Procedimiento para producir una vacuna de herpesvirus, y para produciruna vacuna multivalente.
ATE432085T1 (de) Stimulationsfaktor für dendriten
DK0502146T3 (da) Marek's sygdom - herpesvirus-DNA-segment, der koder for glycoprotein gE
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DE3682893D1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
PT586076E (pt) Vacinas de adenovirus recombinantes
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
DE69033810D1 (de) Herstellung und verwendung des menschlichen nm23-h2-proteins und dagegen gerichtete antikörper
ATE223492T1 (de) Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe
EP0432220A4 (en) Vaccines and diagnostic assays for haemophilus influenzae
MX9602256A (es) Vacuna contra la enfermedad de marek.
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
ATE95422T1 (de) Ein synthetisches nonapeptid zur verwendung als adjuvant.
DE69119785D1 (de) Zweiphasensystem zur herstellung und präsentation von fremdantigenen in hybriden lebendimpfstoffen
Balayeva et al. Protein antigens of genetically related Rickettsia prowazekii strains with different virulence
ATE86308T1 (de) Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse.